Fibroblast Activation Protein α–Directed Imaging and Therapy of Solitary Fibrous Tumor

Interquartile range Solitary Fibrous Tumor
DOI: 10.2967/jnumed.123.266411 Publication Date: 2024-01-10T05:27:45Z
ABSTRACT
Fibroblast activation protein α (FAPα) is expressed at high levels in several types of tumors. Here, we report the expression pattern FAPα solitary fibrous tumor (SFT) and its potential use as a radiotheranostic target. <b>Methods:</b> We analyzed messenger RNA biopsy samples from SFT patients using immunohistochemistry multiplexed immunofluorescence. Tracer uptake detection efficacy were assessed undergoing clinical <sup>68</sup>Ga-FAPα inhibitor (FAPI)–46 PET,<sup>18</sup>F-FDG PET, contrast-enhanced CT. <sup>90</sup>Y-FAPI-46 radioligand therapy was offered to eligible with progressive SFT. <b>Results:</b> Among 813 126 entities prospective observational MASTER program German Cancer Consortium, (<i>n</i> = 34) had highest median expression. Protein confirmed biopsies 29 38 (76%) an independent cohort. Most cases showed intermediate by (24/38 samples, 63%), which located primarily on cell surface. Nineteen who underwent <sup>68</sup>Ga-FAPI-46 PET imaging demonstrated significantly increased uptake, SUV<sub>max</sub> 13.2 (interquartile range [IQR], 10.2), improved mean 94.5% (SEM, 4.2%), compared <sup>18</sup>F-FDG (SUV<sub>max</sub>, 3.2 [IQR, 3.1]; efficacy, 77.3% [SEM, 5.5%]). Eleven received total 34 cycles (median, 3 2 cycles]) therapy, resulted disease control 9 (82%). Median progression-free survival 227 d (IQR, 220 d). <b>Conclusion:</b> highly may serve target for therapy. Further studies are warranted define role FAPα-directed theranostics care patients.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (27)
CITATIONS (8)